Work

A first-in-man phase I study of R306465, a histone deacetylase (HDAC) inhibitor exploring pharmacokinetics (PK) and pharmacodynamics (PD) utilizing an electrochemiluminescent immunoassay in patients (p) with advanced tumours

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3578

Authors: P. C. Fong, S. Settatree, R. Sinha, A. Hardcastle, P. W. Hellemans, J. Arts, K. H. Brown, M. Janicot, W. Aherne, J. S. De Bono

Institutions: Institute of Cancer Research, Royal Marsden Hospital

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2240635070

Cites:

Cited by: 7

Related to: 10